Will pharma companies leaving Ireland for US face tax penalties?

Will pharma companies leaving Ireland for US face tax penalties?

US companies looking to leave Ireland in the wake of Trump's tariffs could face an exit tax of up to 33%

Pharmaceutical exports could be cut by half if tariffs applies, Tánaiste warns

Simon Harris said the tariffs were regrettable and ultimately bad for consumers

Pharmaceutical exports could be cut by half if tariffs applies, Tanaiste warns

Simon Harris said the tariffs were regrettable and ultimately bad for consumers.

Trump’s tariffs loom amid warning trade war could see Irish pharma exports to US halved over five years

{ "themeId": "lct_653b7fa7fed115003648bab8", "clientId": "64772ae4d1d7dec0c5b716af", "liveblogId": "67ea5efb9b66b38dded9cb29" }

Big Pharma Faces Tariff Fears—Will K-Beauty Gain an Edge?

Pharmaceutical Giants Brace for Tariff Impact  The U.S. and European Union are locked in a trade dispute that could result in heavy tariffs on European-made medical goods. Major pharmaceutical companies like Novo Nordisk and Merck fear that increased costs on blockbuster drugs—such as the weight-loss drug Wegovy and the cancer treatment Keytruda—will disrupt supply chains and limit patient access. Industry leaders are calling on policymakers to …

Considered a tax haven by U.S. companies, Ireland has greatly enriched itself through trade, becoming one of the world's leading exporters of drugs and digital services. But Donald Trump's protectionist measures could jeopardize his economic model.